Nuo Therapeutics (AURX) EBITDA (2009 - 2026)
Nuo Therapeutics (AURX) posted EBITDA of -$140,354 for Q2 2026, compared with -$628,966 a year earlier.
Powered by 
Analysis
Nuo Therapeutics (AURX) EBITDA (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Nuo Therapeutics was -$1.84 million; for FY2025, it came in at -$2.43 million.
- In prior years, Nuo Therapeutics' EBITDA was -$2.43 million in FY2024, -$3.15 million in FY2023, -$3.31 million in FY2022 and -$90,670 in FY2021.
- The Q2 2026 figure stands as the highest quarterly EBITDA since Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 3.09 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 2.61 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 1.97 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 789.70 Mn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 2.49 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 1.19 Bn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 344.00 Mn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 769.00 Mn |
| 10 | Nuo Therapeutics | 51.81 Mn | 50.03 Mn | 1.17 Mn | -140,354.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -140,354.00 |
| Mar 31, 2026 | -424,210.00 |
| Dec 31, 2025 | -555,426.00 |
| Sep 30, 2025 | -516,994.00 |
| Jun 30, 2025 | -628,966.00 |
| Mar 31, 2025 | -729,800.00 |
| Dec 31, 2024 | -617,718.00 |
| Sep 30, 2024 | -573,401.00 |
| Jun 30, 2024 | -538,215.00 |
| Mar 31, 2024 | -705,479.00 |
| Dec 31, 2023 | -648,338.00 |
| Sep 30, 2023 | -785,881.00 |
| Jun 30, 2023 | -867,636.00 |
| Mar 31, 2023 | -851,092.00 |
| Dec 31, 2022 | -960,417.00 |
| Sep 30, 2022 | -909,162.00 |
| Jun 30, 2022 | -922,370.00 |
| Mar 31, 2022 | -521,818.00 |
| Dec 31, 2021 | -71,652.00 |
| Sep 30, 2021 | -6,751.00 |
API Access
Nuo Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AURX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AURX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AURX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();